AbbVie hopes risankizumab will rebuild sales after Humira patent expires
Drug Discovery conference 2018
Partnership will use novel approach to treating Alzheimer’s.
Cancer Drugs Fund will reimburse medicine on interim basis
Focus shifts to Keytruda amid competition from Gilead and shrinking market.
Deal with Amgen signals exclusivity until 2023 for mega-blockbuster